Neurosurgical interventions have shown varying outcomes based on the specific conditions treated and the methodologies employed. A retrospective multicenter cohort study analyzed the relationship between histopathological diagnosis and seizure outcomes post-epilepsy surgery, revealing that the proportion of patients achieving Engel class 1 and being drug-free ranged from 0-14% at one year to 14-51% at five years (ref: Lamberink doi.org/10.1016/S1474-4422(20)30220-9/). Another study focused on pulmonary artery denervation (PADN) for patients with residual pulmonary hypertension after pulmonary endarterectomy, demonstrating that while the procedure was generally safe, complications such as groin hematomas occurred in a small number of patients (ref: Romanov doi.org/10.1016/j.jacc.2020.06.064/). In the realm of glioma treatment, a phase I trial evaluated convection-enhanced delivery of targeted cytotoxins in dogs, establishing safety and preliminary efficacy, which could inform future human applications (ref: Rossmeisl doi.org/10.1093/neuonc/). Furthermore, the role of neutrophil extracellular traps in vascular remodeling during retinopathy was investigated, highlighting their unconventional involvement in tissue remodeling processes (ref: Binet doi.org/10.1126/science.aay5356/). The influence of epidermal growth factor receptor (EGFR) expression on glioblastoma response to dopamine receptor D2 inhibitors was also explored, revealing that high EGFR levels correlate with poor treatment outcomes (ref: He doi.org/10.1093/neuonc/). Lastly, the impact of histone deacetylase inhibition on MYC function in medulloblastoma was examined, showing that such inhibition reduces MYC's chromatin binding and alters gene expression profiles (ref: Ecker doi.org/10.1093/neuonc/).